| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: a randomized, controlled trial.
|
Arthritis Rheum
|
2004
|
6.22
|
|
2
|
Predictors of joint damage in patients with early rheumatoid arthritis treated with high-dose methotrexate with or without concomitant infliximab: results from the ASPIRE trial.
|
Arthritis Rheum
|
2006
|
3.29
|
|
3
|
Radiographic findings following two years of infliximab therapy in patients with ankylosing spondylitis.
|
Arthritis Rheum
|
2008
|
2.75
|
|
4
|
Ankylosing Spondylitis Disease Activity Score (ASDAS): defining cut-off values for disease activity states and improvement scores.
|
Ann Rheum Dis
|
2010
|
2.34
|
|
5
|
Golimumab monotherapy in Japanese patients with active rheumatoid arthritis despite prior treatment with disease-modifying antirheumatic drugs: results of the phase 2/3, multicentre, randomised, double-blind, placebo-controlled GO-MONO study through 24 weeks.
|
Ann Rheum Dis
|
2012
|
2.18
|
|
6
|
Intravenous golimumab is effective in patients with active rheumatoid arthritis despite methotrexate therapy with responses as early as week 2: results of the phase 3, randomised, multicentre, double-blind, placebo-controlled GO-FURTHER trial.
|
Ann Rheum Dis
|
2012
|
2.03
|
|
7
|
MRI inflammation at the vertebral unit only marginally predicts new syndesmophyte formation: a multilevel analysis in patients with ankylosing spondylitis.
|
Ann Rheum Dis
|
2011
|
1.90
|
|
8
|
Multiple mechanisms linked to platelet activation result in lysophosphatidic acid and sphingosine 1-phosphate generation in blood.
|
J Biol Chem
|
2002
|
1.72
|
|
9
|
Infliximab induction therapy for patients with severe plaque-type psoriasis: a randomized, double-blind, placebo-controlled trial.
|
J Am Acad Dermatol
|
2004
|
1.66
|
|
10
|
Pharmacokinetics and safety of golimumab, a fully human anti-TNF-alpha monoclonal antibody, in subjects with rheumatoid arthritis.
|
J Clin Pharmacol
|
2007
|
1.62
|
|
11
|
The natural history of spondylolysis and spondylolisthesis: 45-year follow-up evaluation.
|
Spine (Phila Pa 1976)
|
2003
|
1.59
|
|
12
|
Both structural damage and inflammation of the spine contribute to impairment of spinal mobility in patients with ankylosing spondylitis.
|
Ann Rheum Dis
|
2010
|
1.43
|
|
13
|
Double-blinded infliximab dose escalation in patients with rheumatoid arthritis.
|
Ann Rheum Dis
|
2007
|
1.37
|
|
14
|
Infliximab treatment maintains employability in patients with early rheumatoid arthritis.
|
Arthritis Rheum
|
2006
|
1.36
|
|
15
|
Identification of residues responsible for ligand recognition and regioisomeric selectivity of lysophosphatidic acid receptors expressed in mammalian cells.
|
J Biol Chem
|
2005
|
1.34
|
|
16
|
Efficacy and safety of infliximab in patients with ankylosing spondylitis over a two-year period.
|
Arthritis Rheum
|
2008
|
1.27
|
|
17
|
Golimumab, a new human anti-tumor necrosis factor alpha antibody, administered intravenously in patients with active rheumatoid arthritis: Forty-eight-week efficacy and safety results of a phase III randomized, double-blind, placebo-controlled study.
|
Arthritis Rheum
|
2010
|
1.27
|
|
18
|
(+/-)-3-Oxocyclopentanecarboxylic acid: The smallest keto acid known to aggregate by catemeric hydrogen bonding.
|
Acta Crystallogr C
|
2006
|
1.18
|
|
19
|
Golimumab in combination with methotrexate in Japanese patients with active rheumatoid arthritis: results of the GO-FORTH study.
|
Ann Rheum Dis
|
2011
|
1.16
|
|
20
|
Comparison of employability outcomes among patients with early or long-standing rheumatoid arthritis.
|
Arthritis Rheum
|
2008
|
1.08
|
|
21
|
Application of the DAREA/DAPSA score for assessment of disease activity in psoriatic arthritis.
|
Ann Rheum Dis
|
2010
|
1.06
|
|
22
|
Changes in biomarkers of inflammation and bone turnover and associations with clinical efficacy following infliximab plus methotrexate therapy in patients with early rheumatoid arthritis.
|
J Rheumatol
|
2007
|
1.02
|
|
23
|
MRI inflammation and its relation with measures of clinical disease activity and different treatment responses in patients with ankylosing spondylitis treated with a tumour necrosis factor inhibitor.
|
Ann Rheum Dis
|
2012
|
1.00
|
|
24
|
Ustekinumab: lessons learned from targeting interleukin-12/23p40 in immune-mediated diseases.
|
Ann N Y Acad Sci
|
2009
|
0.97
|
|
25
|
Population pharmacokinetics of golimumab, an anti-tumor necrosis factor-alpha human monoclonal antibody, in patients with psoriatic arthritis.
|
J Clin Pharmacol
|
2009
|
0.94
|
|
26
|
Increase coverage of HIV and AIDS services in Myanmar.
|
Confl Health
|
2008
|
0.93
|
|
27
|
A stratified model for health outcomes in ankylosing spondylitis.
|
Ann Rheum Dis
|
2011
|
0.92
|
|
28
|
The impact of infliximab treatment on quality of life in patients with inflammatory rheumatic diseases.
|
Arthritis Res Ther
|
2007
|
0.92
|
|
29
|
Association of anemia and physical disability among patients with rheumatoid arthritis.
|
J Rheumatol
|
2007
|
0.88
|
|
30
|
Multi-platform comparison of ten commercial master mixes for probe-based real-time polymerase chain reaction detection of bioterrorism threat agents for surge preparedness.
|
Forensic Sci Int
|
2012
|
0.85
|
|
31
|
Response of elderly patients with rheumatoid arthritis to methotrexate or TNF inhibitors compared with younger patients.
|
Rheumatology (Oxford)
|
2009
|
0.85
|
|
32
|
Maintenance of efficacy and safety with subcutaneous golimumab among patients with active rheumatoid arthritis who previously received intravenous golimumab.
|
J Rheumatol
|
2011
|
0.85
|
|
33
|
IgG and IgM anticardiolipin antibodies following treatment with infliximab plus methotrexate in patients with early rheumatoid arthritis.
|
Arthritis Rheum
|
2006
|
0.78
|
|
34
|
Real-time 2D visualization of metabolic activities in zebrafish embryos using a microfluidic technology.
|
Cytometry A
|
2015
|
0.77
|
|
35
|
Swab protocol for rapid laboratory diagnosis of cutaneous anthrax.
|
J Clin Microbiol
|
2012
|
0.75
|
|
36
|
Spatial integration and nonlinear transduction of emotional expression.
|
J Vis
|
2015
|
0.75
|
|
37
|
Category-selective patterns of neural response to scrambled images in the ventral visual pathway.
|
J Vis
|
2015
|
0.75
|
|
38
|
Comparison of four types of suppression using steady-state EEG.
|
J Vis
|
2015
|
0.75
|
|
39
|
Ankylosing spondylitis patients with and without psoriasis do not differ in disease phenotype.
|
Ann Rheum Dis
|
2013
|
0.75
|
|
40
|
Considerations in determination of residual moisture in lyophilized demineralized bone matrix: the role of residual moisture analyzers.
|
Cell Tissue Bank
|
2012
|
0.75
|
|
41
|
Trapezium excision and suture suspensionplasty (TESS) for the treatment of thumb carpometacarpal arthritis.
|
Tech Hand Up Extrem Surg
|
2014
|
0.75
|
|
42
|
Efficacy of golimumab plus methotrexate in methotrexate-naïve patients with severe active rheumatoid arthritis.
|
Clin Rheumatol
|
2014
|
0.75
|